Kestra Medical Technologies, Ltd.
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is trading at $28.46, about ₹2,734 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, up 1.17% today. Indian residents can buy Kestra Medical Technologies from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$27.83
Today's high
$28.95
52 week low
$17.34
52 week high
$30.00
KMTS opened at $28.48, closed previously at $28.13, and has traded between $17.34 and $30.00 over the past 52 weeks.
About
Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.
Key statistics
Avg. volume
368.10K
Market cap
$1.67B
P/E Ratio
-10.66
Price-to-sales ratio
15.63
Enterprise value
$1.16B
Free cash flow yield
-9.64%
Debt-to-equity ratio
0.34
Return on equity
-50.69%
ROIC
-43.73%
Beta
0.62
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$95.13M
Earnings per share
-$2.43
Free cash flow
-$116.59M
Net profit margin
-140.43%
Gross margin
53.89%
EBITDA
-$150.04M
Revenue growth
59.04%
Similar securities
This is not an investment recommendation
How to buy Kestra Medical Technologies from India
Indian residents can buy Kestra Medical Technologies shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Kestra Medical Technologies and place an order
Find Kestra Medical Technologies by name or by its ticker, KMTS, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Kestra Medical Technologies trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Kestra Medical Technologies position in USD and INR. Kestra Medical Technologies pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Kestra Medical Technologies from India
Trading and taxes when buying Kestra Medical Technologies from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneKestra Medical Technologies does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Kestra Medical Technologies stock?
Yes. Kestra Medical Technologies (KMTS) has been listed on NASDAQ since 2025, in the Medical - Instruments & Supplies industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Kestra Medical Technologies share cost in rupees?
One Kestra Medical Technologies share is $28.46 — about ₹2,734 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Kestra Medical Technologies price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Kestra Medical Technologies from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Kestra Medical Technologies?
Yes. One Kestra Medical Technologies share is $28.46, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Kestra Medical Technologies.
How are gains on Kestra Medical Technologies shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Kestra Medical Technologies price. Paasa issues a capital-gains statement for your return.
Does Kestra Medical Technologies pay a dividend?
No. Kestra Medical Technologies does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Kestra Medical Technologies from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Kestra Medical Technologies shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Kestra Medical Technologies shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Kestra Medical Technologies holding, its cost and its closing value.
How do I sell Kestra Medical Technologies and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.